Please use this identifier to cite or link to this item:
Title: Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report.
Austin Authors: Kurda, Dylan;Guduguntla, Geetha;Maingard, Julian T;Kok, Hong Kuan;Lalloo, Shivendra
Affiliation: Interventional Radiology Service, Department of Radiology, Austin Health, Heidelberg, Victoria, Australia
Interventional Radiology, The Canberra Hospital, Canberra, Australia
School of Medicine, Deakin University, Waurn Ponds, Geelong, Australia
Interventional Radiology, Northern Health, Melbourne, Victoria, Australia
Issue Date: 17-May-2019 2019-05-17
Publication information: CVIR endovascular 2019; 2(1): 17
Abstract: Uterine arteriovenous malformations (AVM) are unusual causes of vaginal bleeding. Although hysterectomy is the definitive treatment; uterine artery embolization (UAE) provides an alternative therapeutic option. This case presents a technical report of a uterine AVM treated successfully with transcatheter UAE using precipitating hydrophobic injectable liquid (PHIL) embolic agent. A 41-year-old female, gravida 6, para 4, miscarriage 2, including a molar pregnancy 15 years prior, presented with massive per vaginal bleeding. Pelvic ultrasound demonstrated an acquired AVM as the underlying aetiology for her presentation. The patient underwent bilateral uterine arterial embolization. Four weeks later, there was nearly complete resolution of the AVM and the patient's menstrual cycle was restored 8 weeks after the procedure. Uterine AVM can be treated safely and effectively with UAE using PHIL.
DOI: 10.1186/s42155-019-0059-z
ORCID: 0000-0001-5637-734X
Journal: CVIR endovascular
PubMed URL: 32026176
Type: Journal Article
Subjects: AVM
Uterine artery
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jan 30, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.